UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET FORECAST 2021-2026

  • You are here:
  • Home
  • Reports
  • UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET FORECAST 2021-2026

UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET FORECAST 2021-2026

The United States pharmaceutical continuous manufacturing market is anticipated to record a CAGR of 10.45%, by 2026. The country’s market growth is determined by factors such as, the initiatives introduced by government agencies, the presence of leading players, and the advantages of the free pricing policy. The base year considered for the studied market is 2020, while the forecast period is 2021 to 2026.

UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET FORECAST 2021-2026

United States Pharmaceutical Continuous Manufacturing Market by Product (Integrated Continuous System, Semi-continuous System, Control & Software) by Application (Final Drug Product Manufacturing, Api Manufacturing) by End-user (Pharmaceutical Companies, Contract Manufacturing Organizations, Other End-users)

Request free sample

The United States pharmaceutical continuous manufacturing market is anticipated to record a CAGR of 10.45%, by 2026. The country’s market growth is determined by factors such as, the initiatives introduced by government agencies, the presence of leading players, and the advantages of the free pricing policy. The base year considered for the studied market is 2020, while the forecast period is 2021 to 2026.
united-states-pharmaceutical-continuous-manufacturing-market

To know more about this report, request a free sample copy

As per the Pharmaceutical Research and Manufacturers Association (PhRMA), the United States-based companies conduct more than 50% of the world’s research and development activities, in terms of pharmaceuticals. Besides, they also hold intellectual property rights over the majority of new medicines. The initiatives introduced by the country’s government agencies, in order to facilitate the use of continuous manufacturing technologies, play a crucial role in supplementing the market growth.

For instance, the United States Food and Drug Administration (FDA) encourages pharma corporations to implement continuous manufacturing concepts and deliver accelerated approval processes. In addition, the presence of leading players, including, GEA Group, Munson Machinery Company, and Thermo Fisher Scientific, among others, further reinforces the market. As a result, these factors are set to fuel the pharmaceutical continuous manufacturing market growth in the United States, over the forecast period.

Munson Machinery Company, headquartered in the United States, is among the oldest enterprises in New York, offering continuously operated businesses. As a private and a non-profitable firm, it essentially provides processing machinery. Moreover, the company continually strives to enhance its equipment performance, aligning with the levels of comparable manufacturers, worldwide.

 

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

  1. RESEARCH SCOPE & METHODOLOGY
    • STUDY OBJECTIVES
    • SCOPE OF STUDY
    • METHODOLOGY
    • ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    • MARKET SIZE & ESTIMATES
    • COUNTRY SNAPSHOT
    • COUNTRY ANALYSIS
    • KEY GROWTH ENABLERS
    • KEY CHALLENGES
  3. KEY ANALYTICS
    •    PORTER’S FIVE FORCE ANALYSIS
      • THREAT OF NEW ENTRY
      • THREAT OF SUBSTITUTION
      • BUYER’S POWER
      • SUPPLIER’S POWER
      • COMPETITIVE RIVALRY
    • REGULATORY FRAMEWORK
    • IMPACT OF COVID-19 ON PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET
    • OPPORTUNITY MATRIX
    • VENDOR LANDSCAPE
    • KEY INVESTMENT INSIGHTS
  4. MARKET BY PRODUCT
    • INTEGRATED CONTINUOUS SYSTEM
    • SEMI-CONTINUOUS SYSTEM
    • CONTROL & SOFTWARE
  5. MARKET BY APPLICATION
    • FINAL DRUG PRODUCT MANUFACTURING
    • API MANUFACTURING
  6. MARKET BY END-USER
    • PHARMACEUTICAL COMPANIES
    • CONTRACT MANUFACTURING ORGANIZATIONS
    • OTHER END-USERS
  7. COMPETITIVE LANDSCAPE
    •    KEY STRATEGIC DEVELOPMENTS
      • MERGER & ACQUISITIONS
      • PRODUCT LAUNCH & DEVELOPMENTS
      • PARTNERSHIP, CONTRACT/AGREEMENT & COLLABORATION
      • BUSINESS EXPANSION/ APPROVAL/ ANNOUNCEMENT
    •    COMPANY PROFILES
      • MUNSON MACHINERY COMPANY
      • PFIZER INC
      • THERMO FISHER SCIENTIFIC INC
      • ELI LILLY & COMPANY
      • SIEMENS HEALTHINEERS

TABLE LIST

TABLE 1: MARKET SNAPSHOT – PHARMACEUTICAL CONTINUOUS MANUFACTURING

TABLE 2: UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 3: UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY PRODUCT, FORECAST YEARS, 2021-2026 (IN $ MILLION)

TABLE 4: UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 5: UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY APPLICATION, FORECAST YEARS, 2021-2026 (IN $ MILLION)

TABLE 6: UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 7: UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY END-USER, FORECAST YEARS, 2021-2026 (IN $ MILLION)

FIGURE LIST

FIGURE 1: PORTER’S FIVE FORCE ANALYSIS

FIGURE 2: OPPORTUNITY MATRIX

FIGURE 3: VENDOR LANDSCAPE

FIGURE 4: KEY INVESTMENT INSIGHTS

FIGURE 5: UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY PRODUCT, IN 2020

FIGURE 6: UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY INTEGRATED CONTINUOUS SYSTEM, 2021-2026 (IN $ MILLION)

FIGURE 7: UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY SEMI-CONTINUOUS SYSTEM, 2021-2026 (IN $ MILLION)

FIGURE 8: UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY CONTROL & SOFTWARE, 2021-2026 (IN $ MILLION)

FIGURE 9: UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY APPLICATION, IN 2020

FIGURE 10: UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY FINAL DRUG PRODUCT MANUFACTURING, 2021-2026 (IN $ MILLION)

FIGURE 11: UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY API MANUFACTURING, 2021-2026 (IN $ MILLION)

FIGURE 12: UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY END-USER, IN 2020

FIGURE 13: UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY PHARMACEUTICAL COMPANIES, 2021-2026 (IN $ MILLION)

FIGURE 14: UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY CONTRACT MANUFACTURING ORGANIZATIONS, 2021-2026 (IN $ MILLION)

FIGURE 15: UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY OTHER END-USERS, 2021-2026 (IN $ MILLION)

  1. MARKET BY PRODUCT
    • INTEGRATED CONTINUOUS SYSTEM
    • SEMI-CONTINUOUS SYSTEM
    • CONTROL & SOFTWARE
  2. MARKET BY APPLICATION
    • FINAL DRUG PRODUCT MANUFACTURING
    • API MANUFACTURING
  3. MARKET BY END-USER
    • PHARMACEUTICAL COMPANIES
    • CONTRACT MANUFACTURING ORGANIZATIONS
    • OTHER END-USERS

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Add to Cart